lisuride has been researched along with pergolide in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (47.92) | 18.7374 |
1990's | 11 (22.92) | 18.2507 |
2000's | 11 (22.92) | 29.6817 |
2010's | 2 (4.17) | 24.3611 |
2020's | 1 (2.08) | 2.80 |
Authors | Studies |
---|---|
Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
Hamblin, MW; Jose, PA; Metcalf, MA; Monsma, FJ; Shen, Y; Sibley, DR | 1 |
Dolak, LA; Duncan, JN; Heier, RF; Hyslop, DK; Lipton, MF; Martin, IJ; Mauragis, MA; Moon, MW; Nichols, NF; Piercey, MF; Schreur, PJ; Smith, MW | 1 |
Brusniak, MY; DuRand, C; Ginsburg, B; Neve, KA; Pearlman, RS; Starr, S; Teeter, M; Tseng, T; Wilcox, RE | 1 |
Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
Audinot, V; Boutin, JA; Cussac, D; Maiofiss, L; Millan, MJ; Newman-Tancredi, A | 1 |
Boeckler, F; Gmeiner, P; Hübner, H; Lehmann, T; Ohnmacht, U; Utz, W | 1 |
Christoffersen, CT; Jensen, AA; Kehler, J; Krogsgaard-Larsen, N; Schrøder, TJ | 1 |
Diederich, NJ; Goetz, CG | 1 |
Bogdanov, MB; Gaĭnetdinov, RR; Kudrin, VS; Raevskiĭ, KS | 1 |
Ogawa, N | 1 |
Avidan, D; Baron, E; Berezin, M | 1 |
Rinne, UK | 2 |
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
Baumann, G; Chin, L; Lieberman, A | 1 |
Bustos, JC; de Yebenes, JG; Fahn, S; Jackson-Lewis, V; Jorge, P; Lovelle, S; Magariños, C; Martinez, A; Mena, MA; Reiriz, J | 1 |
Jones, JH; Lotti, VJ; Martin, GE; Pettibone, DJ; Taylor, DA; Williams, M; Zrada, MM | 1 |
Svensson, L | 1 |
Carboni, E; Deidda, S; Di Chiara, G; Longoni, R | 1 |
Crosignani, PG; Ferrari, C | 1 |
Goldstein, M; Lieberman, AN | 1 |
Pepperell, RJ | 1 |
Agid, Y; Dubois, B | 1 |
Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Walker, R | 1 |
Burton, K; Calne, DB | 1 |
Lees, AJ; Stern, GM | 1 |
Ku, BS; Takeuchi, H | 1 |
Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A | 1 |
Bergstrom, DA; Bromley, SD; Walters, JR | 1 |
Brincat, S; Lang, AE; Marsden, CD; Parkes, D; Quinn, NP; Sheehy, MP | 1 |
Thompson, C | 1 |
González, ER | 1 |
Canesi, M; Mariani, CB; Pesenti, A; Pezzoli, G | 1 |
Allain, H; Bentué-Ferrer, D; Cardwell, GP; Hicks, CA; O'Neill, MJ; Reymann, JM; Ward, MA | 1 |
Montastruc, JL; Rascol, O; Senard, JM | 1 |
Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O | 1 |
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
Gekht, AB | 1 |
Eich, E; Kren, V; Pertz, HH | 1 |
Gerlach, M; Reichmann, H; Riederer, P | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Bordet, R; Derambure, P; Destée, A; Houdayer, E; Jacquesson, JM; Laloux, C; Monaca, C | 1 |
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R | 1 |
13 review(s) available for lisuride and pergolide
Article | Year |
---|---|
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
[New anti-parkinsonian drugs].
Topics: Antiparkinson Agents; Bromocriptine; Humans; Lisuride; Parkinson Disease; Pergolide; Picolinic Acids; Selegiline | 1991 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
Pergolide mesylate in Parkinson's disease treatment.
Topics: Antiparkinson Agents; Bromocriptine; Controlled Clinical Trials as Topic; Dopamine Agonists; Humans; Lisuride; Neuroprotective Agents; Pergolide | 1995 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2 | 2021 |
1 trial(s) available for lisuride and pergolide
Article | Year |
---|---|
Pergolide and lisuride for levodopa-induced oscillations.
Topics: Clinical Trials as Topic; Ergolines; Female; Humans; Lisuride; Male; Parkinson Disease; Pergolide | 1981 |
34 other study(ies) available for lisuride and pergolide
Article | Year |
---|---|
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Cell Line; Cell Membrane; Cloning, Molecular; Cyclic AMP; Gene Expression; Kidney Tubules, Proximal; Lysergic Acid Diethylamide; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Radioligand Assay; Rats; Receptors, Serotonin; Recombinant Proteins; Serotonin; Transfection | 1993 |
Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites.
Topics: Aminoquinolines; Animals; Dopamine Agonists; Imidazoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Methylamines; Mice; Microsomes, Liver; Molecular Structure; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Serotonin Receptor Agonists; Stereoisomerism | 1997 |
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Topics: Animals; Binding Sites; Databases, Factual; Dopamine Agonists; Humans; Ligands; Macaca mulatta; Models, Molecular; Molecular Conformation; Protein Structure, Secondary; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
Topics: Animals; Antiparkinson Agents; Binding Sites; Binding, Competitive; Cholinergic Antagonists; Cloning, Molecular; Cluster Analysis; Dopamine Agonists; Humans; Rats; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin | 2002 |
CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.
Topics: Animals; Binding Sites; Cattle; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Humans; Indolizines; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereoisomerism | 2005 |
Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT₆ and dopamine D₂ receptor ligands.
Topics: Ergolines; Humans; Ligands; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists | 2014 |
[Selective analyzers of dopamine D2 receptors modulate serotonin metabolism in the striatum and nucleus accumbens of the rat brain during blockade of dopaminergic impulse flow].
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Lisuride; Male; Nucleus Accumbens; Pergolide; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Serotonin | 1992 |
Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dopaminergic drugs.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lisuride; Magnetic Resonance Imaging; Male; Middle Aged; Pergolide; Prolactin; Tomography, X-Ray Computed | 1991 |
Early dopamine agonist therapy in Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine | 1989 |
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
Topics: Animals; Brain; Corpus Striatum; Dopamine; Dopamine Agents; Infusion Pumps; Injections, Intraventricular; Lisuride; Macaca fascicularis; Male; Neural Pathways; Parkinson Disease, Secondary; Pergolide; Rats; Receptors, Dopamine; Selegiline; Stereotyped Behavior; Substantia Nigra | 1987 |
Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
Topics: Animals; Apomorphine; Cats; Clonidine; Ergolines; In Vitro Techniques; Lisuride; Male; Muscle Contraction; Mydriatics; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Vas Deferens | 1985 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Ergolines; Lisuride; Male; Metergoline; Methiothepin; Naphthalenes; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Reflex, Startle; Tetrahydronaphthalenes | 1985 |
SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Body Temperature; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1986 |
Management of prolactinomas. A reappraisal.
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1985 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.
Topics: Adult; Aged; Alanine Transaminase; Antiparkinson Agents; Aspartate Aminotransferases; Cognition Disorders; Dopamine; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Nausea; Neurologic Examination; Parkinson Disease; Pergolide; Vasculitis | 1985 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Effects of synthetic ergot derivatives on the two identifiable giant neurons, sensitive to dopamine, of Achatina fulica Ferussac.
Topics: Animals; Antiparkinson Agents; Chemical Phenomena; Chemistry; Dopamine; Electrophysiology; Ergolines; Ergot Alkaloids; Lisuride; Neurons; Pergolide; Snails | 1983 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Pergolide and lisuride in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies | 1984 |
Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia.
Topics: Action Potentials; Anesthesia, General; Animals; Apomorphine; Chloral Hydrate; Dopamine; Drug Interactions; Electric Stimulation; Ergolines; Globus Pallidus; Haloperidol; Lisuride; Lysergic Acid Diethylamide; Male; Neurons; Pergolide; Rats; Rats, Inbred Strains | 1984 |
Lisuride and pergolide in Parkinson's disease.
Topics: Aged; Disability Evaluation; Dose-Response Relationship, Drug; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Sleep | 1983 |
Anwesenheit: psychopathology and clinical associations.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Epilepsy, Temporal Lobe; Ergolines; Grief; Humans; Lisuride; Male; Middle Aged; Pergolide; Schizophrenic Psychology; Sleep Wake Disorders | 1982 |
Parkinson's disease: new drugs help but no cure on the horizon.
Topics: Antiparkinson Agents; Ergolines; Humans; Lisuride; Parkinson Disease; Pergolide | 1981 |
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Gerbillinae; Haloperidol; Hippocampus; Lisuride; Neuroprotective Agents; Pergolide; Receptors, Dopamine D2 | 1998 |
Sleep attacks and Parkinson's disease treatment.
Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil | 2000 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery.
Topics: Animals; Arteries; Dimerization; Dopamine Agonists; Dose-Response Relationship, Drug; Lisuride; Male; Peptide Fragments; Pergolide; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin; Tail; Vasoconstriction | 2004 |
Levodopa in the treatment of Parkinson's disease: current controversies.
Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide | 2005 |
Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice.
Topics: Animals; Dopamine Agonists; Electroencephalography; Levodopa; Lisuride; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Pergolide; Polysomnography; Sleep; Wakefulness | 2008 |